Drugs / NeoMTA
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03254290 | Oct 2017 → Jun 2018 | dental caries | Texas A & M University Baylor College Of Dentistry | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02702505 | Nov 2014 → Dec 2017 | pulpitis | Texas A & M University Baylor College Of Dentistry | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NeoMTA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03254290 ↗ |
| Known as | NeoMTA Plus | “The study will use a within-subject control design whereby one tooth will be treated with a pulpotomy using the new formulation of MTA (NeoMTA Plus, Avalon Biomed Inc.,...” NCT02702505 ↗ |